The so-called precisionFDA system will provide a forum for sharing data and software as well as deriving standards to enable NGS-based testing
DNANexus will handle data from CareDx's cell-free transplant assay as well as support its ongoing research and development activities.
Using funds from the California precision medicine initiative, the group will use its bioinformatics expertise to match patients to treatments in pediatric clinical trials.
The initiative aims to integrate clinical, genomic, environmental, and other data from patients to help determine disease mechanisms and develop precise therapies.
DNAnexus' platform will support data analysis and sharing for the third phase of the Encyclopedia of DNA Elements project.
The so-called HgV platform offers tools for analyzing high-throughput whole genome sequence data for precision medicine research and clinical applications
The 3000 Rice Genomes Project will use DNANexus' platform in effort to improve nutrition, climate tolerance, and disease resistance in rice.
In addition to the investment, WuXi NextCode is partnering with DNAnexus to offer cloud-based analysis infrastructure to customers in China.
Customers of both companies' cloud-based platforms will have access to their respective genome analysis and interpretation pipelines.
Under the terms of the agreement, Garvan Institute will use DNAnexus' platform to support a number of genomics-based research initiatives
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.